Drugs Made In America Acquisition Corp. | SPAC Research

Drugs Made In America Acquisition Corp.

Status: Live Deal

U=S+R R=S/8

IPO Proceeds, $M	$230.00M
IPO Date	Jan 28, 2025
CEO	Roger Bendelac
Left Lead	Clear Street
IPO Cash in Trust	100.5%
SPAC Tenor	15+12
IPO Sector	Healthcare ▶
IPO Geography	Global
Target Company	Power Analytics Global Corp
Deal Announced	May 5, 2026
Deal Size, $M	TBD
Deal Sector	Technology
Deal Geography	US/Canada
SEC Filings	www.sec.gov
Approval Vote	TBD
Amendment Vote	Apr 27, 2026

DMAA DMAAU DMAAR

Price	$10.60
Last closing price	$10.60
H/L, today	$10.60 / $10.60
Volume, today	107
Volume, 3-month avg.	N/A

Price	$10.58
Last closing price	$10.69
High/low price, today	$10.57 / $10.58
Volume, today	3
Volume, 3-month avg.	N/A

Price
Volume, today
Volume, 3-month avg.	N/A

Price	$0.12
Last closing price	$0.13
High/low price, today	$0.12 / $0.14
Volume, today	89,568
Volume, 3-month avg.	N/A

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.